InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Intercure Ltd.

INCR Clue Score42
Israel Fiscal year ends December CIK 0001857030
$5.17 +2.78% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $5.17 −24.08% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 1 Sep 2021. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2019Revenue8.9Operating income−3.4Net income−5.9EPS, diluted−0.25Fiscal year 2020Revenue65.0 +628.6%Operating income−38.4Net income−37.2EPS, diluted−1.42Fiscal year 2021Revenue219.7 +237.8%Operating income28.2Net income4.7EPS, diluted0.11Fiscal year 2022Revenue388.7 +76.9%Operating income50.6Net income44.8 +855.6%EPS, diluted0.99 +800.0%Fiscal year 2023Revenue355.6 −8.5%Operating income−41.6Net income−62.0 −238.2%EPS, diluted−1.36 −237.4%Fiscal year 2024Revenue238.8 −32.8%Operating income−67.2Net income−67.8EPS, diluted−1.48
FY2019FY2020FY2021FY2022FY2023FY2024
Revenue 8.9 65.0 219.7 388.7 355.6 238.8
Growth +628.6% +237.8% +76.9% −8.5% −32.8%
Operating income −3.4 −38.4 28.2 50.6 −41.6 −67.2
Net income −5.9 −37.2 4.7 44.8 −62.0 −67.8
Growth +855.6% −238.2%
EPS, diluted −0.25 −1.42 0.11 0.99 −1.36 −1.48
Growth +800.0% −237.4%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2019Gross margin16.6%Operating margin−38.3%Net margin−66.0%Free cash flow margin−444.9%Fiscal year 2020Gross margin49.2%Operating margin−59.0%Net margin−57.2%Free cash flow margin−19.9%Fiscal year 2021Gross margin41.5%Operating margin12.8%Net margin2.1%Free cash flow margin7.3%Fiscal year 2022Gross margin39.9%Operating margin13.0%Net margin11.5%Free cash flow margin8.1%Fiscal year 2023Gross margin29.6%Operating margin−11.7%Net margin−17.4%Free cash flow margin−15.8%Fiscal year 2024Gross margin12.7%Operating margin−28.1%Net margin−28.4%Free cash flow margin−29.9%
FY2019FY2020FY2021FY2022FY2023FY2024
Gross margin 16.6% 49.2% 41.5% 39.9% 29.6% 12.7%
Operating margin −38.3% −59.0% 12.8% 13.0% −11.7% −28.1%
Net margin −66.0% −57.2% 2.1% 11.5% −17.4% −28.4%
Free cash flow margin −444.9% −19.9% 7.3% 8.1% −15.8% −29.9%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2019Operating cash flow−11.6Capital expenditure−28.1Free cash flow−39.7Fiscal year 2020Operating cash flow7.9Capital expenditure−20.8Free cash flow−12.9Fiscal year 2021Operating cash flow30.1Capital expenditure−14.0Free cash flow16.1Fiscal year 2022Operating cash flow51.3Capital expenditure−19.7Free cash flow31.5 +95.7%Fiscal year 2023Operating cash flow−53.6Capital expenditure−2.6Free cash flow−56.3 −278.4%Fiscal year 2024Operating cash flow−66.9Capital expenditure−4.4Free cash flow−71.3
FY2019FY2020FY2021FY2022FY2023FY2024
Operating cash flow −11.6 7.9 30.1 51.3 −53.6 −66.9
Capital expenditure −28.1 −20.8 −14.0 −19.7 −2.6 −4.4
Free cash flow −39.7 −12.9 16.1 31.5 −56.3 −71.3
Growth +95.7% −278.4%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2019Cash27.3Shareholders’ equity256.2Fiscal year 2020Cash37.9Total debt0.4Net cash (debt)37.5Shareholders’ equity274.5Debt to equity0.00Fiscal year 2021Cash196.2Total debt11.9Net cash (debt)184.3Shareholders’ equity448.0Debt to equity0.03Fiscal year 2022Cash232.6Total debt99.7Net cash (debt)132.9Shareholders’ equity501.3Debt to equity0.20Fiscal year 2023Cash101.1Total debt132.5Net cash (debt)−31.3Shareholders’ equity455.1Debt to equity0.29Fiscal year 2024Cash78.3Total debt133.3Net cash (debt)−54.9Shareholders’ equity397.0Debt to equity0.34
FY2019FY2020FY2021FY2022FY2023FY2024
Cash 27.3 37.9 196.2 232.6 101.1 78.3
Total debt n/a 0.4 11.9 99.7 132.5 133.3
Net cash (debt) n/a 37.5 184.3 132.9 −31.3 −54.9
Shareholders’ equity 256.2 274.5 448.0 501.3 455.1 397.0
Debt to equity n/a 0.00 0.03 0.20 0.29 0.34

In millions of ILS, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2024 · 10-K

Income statement

In millions of ILS, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024
Revenue and profit
8.9 65.0 219.7 388.7 355.6 238.8
Growth +628.6% +237.8% +76.9% −8.5% −32.8%
7.5 34.6 123.7 229.7 247.2 203.3
1.5 32.0 91.1 155.1 105.1 30.2
Growth +2,061.9% +185.0% +70.2% −32.2% −71.2%
1.7 1.6 1.2 0.6 0.4 0.4
12.1 8.6 27.2 36.1 42.6 53.7
−3.4 −38.4 28.2 50.6 −41.6 −67.2
Growth +79.6% −182.1%
−6.6 −38.3 18.7 43.8 −61.3 −87.3
−0.7 −2.3 11.4 0.1 2.2 −14.5
−5.9 −37.2 4.7 44.8 −62.0 −67.8
Growth +855.6% −238.2%
Per share
−0.25 −1.42 0.12 0.99 −1.36 −1.48
−0.25 −1.42 0.11 0.99 −1.36 −1.48
Growth +800.0% −237.4%
23.3 25.4 38.5 45.4 45.6 45.9

Shown in ILS as filed; the screener converts to dollars.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 93.0% a year over five years.
  • Operating margin is up 10.1 points on five years ago, at -28.1%.
  • A net loss in 4 of 6 years on file.